Home > Balance Sheet > MANKIND PHARMA

MANKIND PHARMA
Total Non-Current Liabilities

    Back to Balance Sheet
MANKIND PHARMA is part of below Screeners ↓
Top Mid Cap Stocks with Best Fundamentals
Best Quarterly Growth Mid Cap Stocks
COMMUNITY POLL
for MANKIND PHARMA
Please provide your vote to see the results

MANKIND PHARMA Last 5 Year Total Non-Current Liabilities History

[Consolidated]

Mar2026Mar2025Mar2024Mar2023Mar2022
Total Non-Current Liabilities ₹4,687 Cr₹7,420 Cr₹187 Cr₹199 Cr₹169 Cr

What is the latest Total Non-Current Liabilities ratio of MANKIND PHARMA ?

The latest Total Non-Current Liabilities ratio of MANKIND PHARMA is ₹4,687 Cr based on Mar2026 Consolidated results.
Year Total Non-Current Liabilities
Mar2026₹4,687 Cr
Mar2025₹7,420 Cr
Mar2024₹187 Cr
Mar2023₹199 Cr
Mar2022₹169 Cr

How is Total Non-Current Liabilities of MANKIND PHARMA Trending?

Years Total Non-Current Liabilities % Change
Mar2026 ₹4,687 Cr
-36.84
Mar2025 ₹7,420 Cr
3,860.66
Mar2024 ₹187 Cr
-5.97
Mar2023 ₹199 Cr
18.12
Mar2022 ₹169 Cr -

Compare Total Non-Current Liabilities of peers of MANKIND PHARMA

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
MANKIND PHARMA ₹93,003.5 Cr -5.2% 1.2% -4.2% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹418,684.0 Cr 0.1% -5% 5.4% Stock Analytics
DIVIS LABORATORIES ₹241,311.0 Cr -1.7% 0.2% 39.5% Stock Analytics
TORRENT PHARMACEUTICALS ₹173,079.0 Cr -2.5% -5.5% 30.2% Stock Analytics
CIPLA ₹107,528.0 Cr 0.9% -2.6% -14.6% Stock Analytics
DR REDDYS LABORATORIES ₹103,667.0 Cr 0.1% 7.6% -3.5% Stock Analytics


MANKIND PHARMA Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
MANKIND PHARMA

-5.2%

1.2%

-4.2%

SENSEX

3.1%

1%

-9.1%


You may also like the below Video Courses